A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy - The Baylor experience (1996-2002)

Clinical Cardiology

Volumn 28, Issue 3, 2005, Pages 124-130

  Fernandes, Valerian L ^a   Nagueh, Sherif F ^b   Franklin, Jennifer ^a   Wang, Wei ^b   Roberts, Robert ^a   Spencer III, William H ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Ablation; Alcohol; Cardiomyopathy; Gradient; Hypertrophic; Myectomy; Septal

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL SEPTAL ABLATION; ANGINA PECTORIS; ARTERY DISSECTION; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEATH; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART BLOCK; HEART DEATH; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; TREADMILL EXERCISE; TREATMENT OUTCOME;

EID: 14944368967     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960280305     Document Type: Article

References (31)

1. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE: Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy (Part 1). N Engl J Med 1987;316(13):780-789
2. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE: Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy (Part 2). N Engl J Med 1987;316:844-852
3. Wigle ED, Rakowski H, Kimball BP, Williams WG: Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation 1995;92:1680-1692
4. Maron BJ, Mathenge R, Casey SA, Poliac LC, Longe TF: Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. J Am Coll Cardiol 1999;33(6):1590-1595
5. Spirito P, Seidman CE, McKenna WJ, Maron BJ: The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336(11):775-785
6. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348(4):295-303
7. Spirito P, Maron BJ: Perspectives on the role of new treatment strategies in hypertrophic cardiomyopathy. J Am Coll Cardiol 1999;33:1071-1075
8. Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN, Allison TG, Tajik AJ: Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29:435-441
9. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS: Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, crossover study (M-PATHY). Circulation 1999;99:2927-2933
10. Morrow AG, Reitz BA, Epstein SE: Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre- and postoperative assessments in 83 patients. Circulation 1975;52:88-102
11. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK: Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996;94(3):467-471
12. Maron BJ, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG: Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 1978;57(6):1205-1213
13. Cohn LH, Trehan H, Collins JJ Jr: Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 1992;70:657-660
14. Schulte HD, Bircks WH, Loesse B, Godehardt EA, Schwartzkopff B: Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years. J Thorac Cardiovasc Surg 1993;106(4):709-717
15. Schulte HD, Borisov K, Gams E, Gramsch-Zabel H, Losse B, Schwartzkopff B: Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy. J Thorac Cardiovasc Surg 1999;47(4):213-218
16. ten Berg JM, Suttorp MJ, Knaepen PJ, Ernst SM, Vermeulen FE, Jaarsma W: Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy. Circulation 1994;90(4):1781-1785
17. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM: Surgical management of hypertrophic obstructive cardiomyopathy: Early and late results. J Thorac Cardiovasc Surg 1995;110:195-206
18. Robbins RC, Stinson EB: Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996;111(3):586-594
19. Gol MK, Emir M, Keles T, Kucuker SA, Birincioglu CL, Karagoz YH, Kural T, Tasdemir O, Goksel S, Bayazit K: Septal myectomy in hypertrophic obstructive cardiomyopathy: Late results with stress echocardiography. Ann Thorac Surg 1997;64(3):739-745
20. Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U: Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 1997;95(8):2075-2081
21. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED: American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713
22. Lakkis N, Plana JC, Nagueh S, Roberts R, Spencer WH III: Efficacy of non-surgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients. Am J Cardiol 2001;88:583-586
23. Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL Jr, Ribeiro LG, Miller RR: A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981;64:744-753
24. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH III: Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998;98(17):1750-1755
25. Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quinones MA, Spencer WH III: Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1999;34:1123-1128
26. Faber L, Meissner A, Ziemssen P, Seggewiss H: Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: Long-term follow-up of the first series of 25 patients. Heart 2000;83(3):326-331
27. Chang SM, Nagueh SF, Spencer WH III, Lakkis NM: Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing non-surgical septal reduction therapy. J Am Coll Cardiol 2003;42:296-300
28. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D: Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-2742
29. Maron BJ: Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet 2000;355:425-426
30. Maron BJ: Hypertrophic cardiomyopathy and sudden death: New perspectives on risk stratification and prevention with the implantable cardioverter- defibrillator. Eur Heart J 2000;21(24):1979-1983
31. Maron BJ, Shen WK, Link MS, Epstein AE, Allmquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-372